Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Comment by inthnoon Nov 25, 2022 11:56am
203 Views
Post# 35128335

RE:Reply to inthno

RE:Reply to inthno
Hello Westcoast. Much appreciated for your response, always nice to get another perspective.
There are so many ways that this could go and BO is still the best and I am sure we will know soon enough. It is possible that if there is an offer or partnership being tabled that we could hear about it before year end but should be before Bracelet for sure. Still thinking it will come down to Matt and what he wants and which way he wants to go so I hope they are all being reasonable to advance this as quickly as possible. I really think that all would be happy with something in the 2-4 billion range although suggestions are that we could be worth a lot more. Would it be worth it to wait that out a few more months for that amount with no guarnatee that a higher price would be offered, that is the question. I do like the trading to day and from my limited viewpoint from what I can see is that there are some larger blocks trading which is nice for a change which could suggest a larger entity is involved but not for sure
<< Previous
Bullboard Posts
Next >>